249 related articles for article (PubMed ID: 23686423)
21. T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.
de Leval L; Harris NL; Lampertz S; Herens C
APMIS; 2006 Jun; 114(6):474-8. PubMed ID: 16856972
[TBL] [Abstract][Full Text] [Related]
22. A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma.
Schuhmacher B; Rengstl B; Döring C; Bein J; Newrzela S; Brunnberg U; Kvasnicka HM; Vornanen M; Küppers R; Hansmann ML; Hartmann S
Oncotarget; 2016 Nov; 7(44):72197-72210. PubMed ID: 27708232
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Hartmann S; Dojcinov S; Dotlic S; Gibson SE; Hsi ED; Klapper W; Klimkowska M; Pinilla SMR; Richter J; Sabattini E; Tousseyn T; de Jong D
Virchows Arch; 2023 Oct; 483(4):451-463. PubMed ID: 37530790
[TBL] [Abstract][Full Text] [Related]
24. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia.
Kunder C; Cascio MJ; Bakke A; Venkataraman G; O'Malley DP; Ohgami RS
Am J Clin Pathol; 2017 Jun; 147(6):596-603. PubMed ID: 28575178
[TBL] [Abstract][Full Text] [Related]
25. A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide.
Siricilla M; Irwin L; Ferber A
Case Rep Oncol Med; 2018; 2018():6137454. PubMed ID: 29552367
[TBL] [Abstract][Full Text] [Related]
26. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
27. 3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma.
Sadeghi Shoreh Deli A; Scharf S; Steiner Y; Bein J; Hansmann ML; Hartmann S
Mod Pathol; 2022 Oct; 35(10):1431-1438. PubMed ID: 35173297
[TBL] [Abstract][Full Text] [Related]
28. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
29.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
30. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
[TBL] [Abstract][Full Text] [Related]
31. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Panayi C; Akarca AU; Ramsay AD; Shankar AG; Falini B; Piris MA; Linch D; Marafioti T
Front Oncol; 2023; 13():1267604. PubMed ID: 37854674
[TBL] [Abstract][Full Text] [Related]
32. Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.
Cano I; Lozano M; Rodríguez A; Mate A; Adrados M; López Mdel M; Carro R; Montes-Moreno S
Histopathology; 2010 Jul; 57(1):159-62. PubMed ID: 20653789
[No Abstract] [Full Text] [Related]
33. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
[TBL] [Abstract][Full Text] [Related]
34. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
35. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma.
Hartmann S; Schuhmacher B; Rausch T; Fuller L; Döring C; Weniger M; Lollies A; Weiser C; Thurner L; Rengstl B; Brunnberg U; Vornanen M; Pfreundschuh M; Benes V; Küppers R; Newrzela S; Hansmann ML
Leukemia; 2016 Apr; 30(4):844-53. PubMed ID: 26658840
[TBL] [Abstract][Full Text] [Related]
36. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Hartmann S; Cogliatti S; Hansmann ML
Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
[TBL] [Abstract][Full Text] [Related]
37. Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas-with review of literature on extranodal presentation of this disease.
Bagwan IN; Knee G; Abboudi Z; Naresh KN
J Hematop; 2010 Mar; 3(1):29-34. PubMed ID: 21436871
[TBL] [Abstract][Full Text] [Related]
38. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
39. Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma.
Schmitz C; Rekowski J; Reinke S; Müller SP; Hüttmann A; Klapper W; Dührsen U
Leuk Lymphoma; 2020 Jun; 61(6):1372-1379. PubMed ID: 32022621
[TBL] [Abstract][Full Text] [Related]
40. From a pathologist's point of view: Histiocytic cells in Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S
Pathol Res Pract; 2015 Dec; 211(12):901-4. PubMed ID: 26596262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
